Wednesday, March 6, 2013

US Report Calls For Global Action Enforcement Against Fake Drugs

Image: Counterfeit drugs seized by U.S. Customs & Border Protection are seen on display at the agency's offices at John F. Kennedy Airport 

Counterfeit drugs seized by the U.S. Customs & BorderProtection (CBP) are seen on display at the agency's offices at John F. Kennedy Airport in New York August 15, 2012.

I suppose we should not be surprised that the Institute of Medicine has documented serious problems in our drug supply, with “counterfeit, contaminated and adulterated drugs” in every part of the globe.  Ever since the Chinese dog food scared of 2007, I expected it was only a matter of time before the same lack of standards and regulations affected the human food supply, or worse.  Thankfully the FDA is at least asking the questions, which led to the extensive report released in February.


The report is quite startling, with ramifications that reach every corner of the globe.  Numerous people have died from contaminated medicine in several countries, including the United States.  But possibly even more tragic is the increase in disease fatality due to individuals who believe they are being treated, as well as bacterial adaptations to become drug resistant.  Diseases like tuberculosis are on the rise again, after decades of progress in reducing its spread.  In the 1900s, tuberculosis was responsible for more deaths in the US than cancer.  The potential illness and suffering from bacteria developing resistance has already been documented with MRSA and similar superbugs.

In addition, the majority of the ingredients in our drugs, called APIs (Active Pharmaceutical Ingredients), are imported from countries with even less control, an astounding 40% from China. “The FDA has reported at least 62 deaths in 2007 and 2008 after being given contaminated, a blood thinner, made in China.”The report calls for major investment by the FDA to put in place a track and trace system and increase regulation of pharmacies.  Falsified and substandard drugs have been sold in at least 124 countries and the Institute of Medicine believes the only way to contain the expansion of fake drugs is with a system that monitors each product, “from manufacturer to patient”.

By group #11: Jacklyn, Jakki, Jody, Huy, Thien, Kashif, Roba, and Sergio

No comments:

Post a Comment